A high cytoplasmic NRF3 immunohistochemical expression in melanoma cells in primary melanoma samples correlated with a worse melanoma-specific survival (log-rank test p = 0.006), but only in the patients with nodal metastases at the time of diagnosis (n = 25, Figure 5(a)). This evidence concerns the gene NFE2L3 and melanoma.